Posted by Michael Wonder on 07 Oct 2016
CADTH calls for patient input on a submission from Celopharma for Mifegymiso
6 October 2016 - CADTH is calling for patient input on a submission from Celopharma for its combination product Mifegymiso.
Mifegymiso (mifepristone with misoprostol) is used for the termination of pregnancy. There has been considerable recent public debate in Canada on Celopharma's failure to lodge a submission with CADTH for Mifegymiso.
